Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 865 to 873 of 873 entries
Sorted by: Best Match Show Resources per page
Evaluation of the Implementation of Multiple Enhanced Recovery After Surgery Pathways Across a Provincial Health Care System in Alberta, Canada.

JAMA network open

Nelson G, Wang X, Nelson A, Faris P, Lagendyk L, Wasylak T, Bathe OF, Bigam D, Bruce E, Buie WD, Chong M, Fairey A, Hyndman ME, MacLean A, McCall M, Pin S, Wang H, Gramlich L.
PMID: 34357394
JAMA Netw Open. 2021 Aug 02;4(8):e2119769. doi: 10.1001/jamanetworkopen.2021.19769.

IMPORTANCE: Engaging multidisciplinary care teams in surgical practice is important for the improvement of surgical outcomes.OBJECTIVE: To evaluate the association of multiple Enhanced Recovery After Surgery (ERAS) pathways with ERAS guideline adherence and outcomes.DESIGN, SETTING, AND PARTICIPANTS: This quality...

Cite
Nelson G, Wang X, Nelson A, et al. Evaluation of the Implementation of Multiple Enhanced Recovery After Surgery Pathways Across a Provincial Health Care System in Alberta, Canada. JAMA Netw Open. 2021;4(8):e2119769doi: 10.1001/jamanetworkopen.2021.19769.
Nelson, G., Wang, X., Nelson, A., Faris, P., Lagendyk, L., Wasylak, T., Bathe, O. F., Bigam, D., Bruce, E., Buie, W. D., Chong, M., Fairey, A., Hyndman, M. E., MacLean, A., McCall, M., Pin, S., Wang, H., & Gramlich, L. (2021). Evaluation of the Implementation of Multiple Enhanced Recovery After Surgery Pathways Across a Provincial Health Care System in Alberta, Canada. JAMA network open, 4(8), e2119769. https://doi.org/10.1001/jamanetworkopen.2021.19769
Nelson, Gregg, et al. "Evaluation of the Implementation of Multiple Enhanced Recovery After Surgery Pathways Across a Provincial Health Care System in Alberta, Canada." JAMA network open vol. 4,8 (2021): e2119769. doi: https://doi.org/10.1001/jamanetworkopen.2021.19769
Nelson G, Wang X, Nelson A, Faris P, Lagendyk L, Wasylak T, Bathe OF, Bigam D, Bruce E, Buie WD, Chong M, Fairey A, Hyndman ME, MacLean A, McCall M, Pin S, Wang H, Gramlich L. Evaluation of the Implementation of Multiple Enhanced Recovery After Surgery Pathways Across a Provincial Health Care System in Alberta, Canada. JAMA Netw Open. 2021 Aug 02;4(8):e2119769. doi: 10.1001/jamanetworkopen.2021.19769. PMID: 34357394; PMCID: PMC8346943.
Copy Download .nbib Format: NLM
Low-cost grain sorting technologies to reduce mycotoxin contamination in maize and groundnut.

Food control

Aoun M, Stafstrom W, Priest P, Fuchs J, Windham GL, Williams WP, Nelson RJ.
PMID: 33273755
Food Control. 2020 Dec;118:107363. doi: 10.1016/j.foodcont.2020.107363.

The widespread contamination of foods by mycotoxins continues to be a public health hazard in sub-Saharan Africa, with maize and groundnut being major sources of contamination. This study was undertaken to assess the hypothesis that grain sorting can be...

Cite
Aoun M, Stafstrom W, Priest P, et al. Low-cost grain sorting technologies to reduce mycotoxin contamination in maize and groundnut. Food Control. 2020;118:107363doi: 10.1016/j.foodcont.2020.107363.
Aoun, M., Stafstrom, W., Priest, P., Fuchs, J., Windham, G. L., Williams, W. P., & Nelson, R. J. (2020). Low-cost grain sorting technologies to reduce mycotoxin contamination in maize and groundnut. Food control, 118107363. https://doi.org/10.1016/j.foodcont.2020.107363
Aoun, Meriem, et al. "Low-cost grain sorting technologies to reduce mycotoxin contamination in maize and groundnut." Food control vol. 118 (2020): 107363. doi: https://doi.org/10.1016/j.foodcont.2020.107363
Aoun M, Stafstrom W, Priest P, Fuchs J, Windham GL, Williams WP, Nelson RJ. Low-cost grain sorting technologies to reduce mycotoxin contamination in maize and groundnut. Food Control. 2020 Dec;118:107363. doi: 10.1016/j.foodcont.2020.107363. PMID: 33273755; PMCID: PMC7439795.
Copy Download .nbib Format: NLM
The impact of school opening model on SARS-CoV-2 community incidence and mortality.

Nature medicine

Ertem Z, Schechter-Perkins EM, Oster E, van den Berg P, Epshtein I, Chaiyakunapruk N, Wilson FA, Perencevich E, Pettey WBP, Branch-Elliman W, Nelson RE.
PMID: 34707317
Nat Med. 2021 Dec;27(12):2120-2126. doi: 10.1038/s41591-021-01563-8. Epub 2021 Oct 27.

The role that traditional and hybrid in-person schooling modes contribute to the community incidence of SARS-CoV-2 infections relative to fully remote schooling is unknown. We conducted an event study using a retrospective nationwide cohort evaluating the effect of school...

Cite
Ertem Z, Schechter-Perkins EM, Oster E, et al. The impact of school opening model on SARS-CoV-2 community incidence and mortality. Nat Med. 2021;27(12):2120-2126doi: 10.1038/s41591-021-01563-8.
Ertem, Z., Schechter-Perkins, E. M., Oster, E., van den Berg, P., Epshtein, I., Chaiyakunapruk, N., Wilson, F. A., Perencevich, E., Pettey, W. B. P., Branch-Elliman, W., & Nelson, R. E. (2021). The impact of school opening model on SARS-CoV-2 community incidence and mortality. Nature medicine, 27(12), 2120-2126. https://doi.org/10.1038/s41591-021-01563-8
Ertem, Zeynep, et al. "The impact of school opening model on SARS-CoV-2 community incidence and mortality." Nature medicine vol. 27,12 (2021): 2120-2126. doi: https://doi.org/10.1038/s41591-021-01563-8
Ertem Z, Schechter-Perkins EM, Oster E, van den Berg P, Epshtein I, Chaiyakunapruk N, Wilson FA, Perencevich E, Pettey WBP, Branch-Elliman W, Nelson RE. The impact of school opening model on SARS-CoV-2 community incidence and mortality. Nat Med. 2021 Dec;27(12):2120-2126. doi: 10.1038/s41591-021-01563-8. Epub 2021 Oct 27. PMID: 34707317.
Copy Download .nbib Format: NLM
Effects of High-Fructose Diet .

Journal of obesity and chronic diseases

Kumar A, Lubet RA, Fox JT, Nelson WG, Seifried H, Grubbs CJ, Miller MS.
PMID: 33834161
J Obes Chronic Dis. 2021;5(1):67-78. Epub 2021 Jan 11.

Epidemiology, clinical and experimental animal studies suggest high fructose diets are detrimental to metabolic status and may contribute to tumor development. This due to increased obesity and metabolic syndrome, known risk factors for many types of cancer. We compared...

Cite
Kumar A, Lubet RA, Fox JT, et al. Effects of High-Fructose Diet . J Obes Chronic Dis. 2021;5(1):67-78
Kumar, A., Lubet, R. A., Fox, J. T., Nelson, W. G., Seifried, H., Grubbs, C. J., & Miller, M. S. (2021). Effects of High-Fructose Diet . Journal of obesity and chronic diseases, 5(1), 67-78.
Kumar, Amit, et al. "Effects of High-Fructose Diet ." Journal of obesity and chronic diseases vol. 5,1 (2021): 67-78.
Kumar A, Lubet RA, Fox JT, Nelson WG, Seifried H, Grubbs CJ, Miller MS. Effects of High-Fructose Diet . J Obes Chronic Dis. 2021;5(1):67-78. Epub 2021 Jan 11. PMID: 33834161; PMCID: PMC8026172.
Copy Download .nbib Format: NLM
Protracted clinical course of an AFF1 fusion positive uterine smooth muscle tumor causing diagnostic confusion over a course of 15 years.

Gynecologic oncology reports

Aubrey C, Mal H, Köbel M, Lee CH, Turashvili G, Yip S, Lum A, Nelson G.
PMID: 34926770
Gynecol Oncol Rep. 2021 Nov 17;38:100890. doi: 10.1016/j.gore.2021.100890. eCollection 2021 Nov.

•Histologic diagnostic criteria alone for uterine smooth muscle tumors lacks robust prognostication.•Molecular/genetic techniques should be advocated to further investigate unusual case presentations.•Novel identification of a

Cite
Aubrey C, Mal H, Köbel M, et al. Protracted clinical course of an AFF1 fusion positive uterine smooth muscle tumor causing diagnostic confusion over a course of 15 years. Gynecol Oncol Rep. 2021;38:100890doi: 10.1016/j.gore.2021.100890.
Aubrey, C., Mal, H., Köbel, M., Lee, C. H., Turashvili, G., Yip, S., Lum, A., & Nelson, G. (2021). Protracted clinical course of an AFF1 fusion positive uterine smooth muscle tumor causing diagnostic confusion over a course of 15 years. Gynecologic oncology reports, 38100890. https://doi.org/10.1016/j.gore.2021.100890
Aubrey, Christa, et al. "Protracted clinical course of an AFF1 fusion positive uterine smooth muscle tumor causing diagnostic confusion over a course of 15 years." Gynecologic oncology reports vol. 38 (2021): 100890. doi: https://doi.org/10.1016/j.gore.2021.100890
Aubrey C, Mal H, Köbel M, Lee CH, Turashvili G, Yip S, Lum A, Nelson G. Protracted clinical course of an AFF1 fusion positive uterine smooth muscle tumor causing diagnostic confusion over a course of 15 years. Gynecol Oncol Rep. 2021 Nov 17;38:100890. doi: 10.1016/j.gore.2021.100890. eCollection 2021 Nov. PMID: 34926770; PMCID: PMC8651790.
Copy Download .nbib Format: NLM
Identification of Root Rot Resistance QTLs in Pea Using .

Frontiers in genetics

Williamson-Benavides BA, Sharpe RM, Nelson G, Bodah ET, Porter LD, Dhingra A.
PMID: 34421980
Front Genet. 2021 Aug 05;12:629267. doi: 10.3389/fgene.2021.629267. eCollection 2021.

No abstract available.

Cite
Williamson-Benavides BA, Sharpe RM, Nelson G, et al. Identification of Root Rot Resistance QTLs in Pea Using . Front Genet. 2021;12:629267doi: 10.3389/fgene.2021.629267.
Williamson-Benavides, B. A., Sharpe, R. M., Nelson, G., Bodah, E. T., Porter, L. D., & Dhingra, A. (2021). Identification of Root Rot Resistance QTLs in Pea Using . Frontiers in genetics, 12629267. https://doi.org/10.3389/fgene.2021.629267
Williamson-Benavides, Bruce A, et al. "Identification of Root Rot Resistance QTLs in Pea Using ." Frontiers in genetics vol. 12 (2021): 629267. doi: https://doi.org/10.3389/fgene.2021.629267
Williamson-Benavides BA, Sharpe RM, Nelson G, Bodah ET, Porter LD, Dhingra A. Identification of Root Rot Resistance QTLs in Pea Using . Front Genet. 2021 Aug 05;12:629267. doi: 10.3389/fgene.2021.629267. eCollection 2021. PMID: 34421980; PMCID: PMC8375389.
Copy Download .nbib Format: NLM
Reducing the pain: A cost-effectiveness analysis of transversus abdominis plane block using liposomal bupivacaine for outpatient laparoscopic ventral hernia repair.

Surgery open science

Colonna AL, Bellows BK, Enniss TM, Young JB, McCrum M, Nunez JM, Nirula R, Nelson RE.
PMID: 33997752
Surg Open Sci. 2020 Jan 23;2(2):75-80. doi: 10.1016/j.sopen.2019.12.003. eCollection 2020 Apr.

BACKGROUND: Transversus abdominis plane block with liposomal bupivacaine has been studied as an effective method of reducing the need for postoperative opioids and increasing same-day discharge rates. However, less is known about the cost-effectiveness of this strategy relative to...

Cite
Colonna AL, Bellows BK, Enniss TM, et al. Reducing the pain: A cost-effectiveness analysis of transversus abdominis plane block using liposomal bupivacaine for outpatient laparoscopic ventral hernia repair. Surg Open Sci. 2020;2(2):75-80doi: 10.1016/j.sopen.2019.12.003.
Colonna, A. L., Bellows, B. K., Enniss, T. M., Young, J. B., McCrum, M., Nunez, J. M., Nirula, R., & Nelson, R. E. (2020). Reducing the pain: A cost-effectiveness analysis of transversus abdominis plane block using liposomal bupivacaine for outpatient laparoscopic ventral hernia repair. Surgery open science, 2(2), 75-80. https://doi.org/10.1016/j.sopen.2019.12.003
Colonna, Alexander L, et al. "Reducing the pain: A cost-effectiveness analysis of transversus abdominis plane block using liposomal bupivacaine for outpatient laparoscopic ventral hernia repair." Surgery open science vol. 2,2 (2020): 75-80. doi: https://doi.org/10.1016/j.sopen.2019.12.003
Colonna AL, Bellows BK, Enniss TM, Young JB, McCrum M, Nunez JM, Nirula R, Nelson RE. Reducing the pain: A cost-effectiveness analysis of transversus abdominis plane block using liposomal bupivacaine for outpatient laparoscopic ventral hernia repair. Surg Open Sci. 2020 Jan 23;2(2):75-80. doi: 10.1016/j.sopen.2019.12.003. eCollection 2020 Apr. PMID: 33997752; PMCID: PMC8097728.
Copy Download .nbib Format: NLM
A mixed-methods study to evaluate a patient-designed tool to reduce harm from cancer-associated thrombosis: The EMPOWER study.

Research and practice in thrombosis and haemostasis

Baddeley E, Torrens-Burton A, Newman A, Nelson A, Pease N, Nelson R, Noble S.
PMID: 34401640
Res Pract Thromb Haemost. 2021 Aug 11;5(5):e12545. doi: 10.1002/rth2.12545. eCollection 2021 Jul.

INTRODUCTION: Venous thromboembolism (VTE) is a common and serious complication of systemic anticancer therapies. Delays in presentation increase risk of death or long-term morbidity.BACKGROUND: A patient charity developed an information video for patients receiving systemic anticancer therapy including what...

Cite
Baddeley E, Torrens-Burton A, Newman A, et al. A mixed-methods study to evaluate a patient-designed tool to reduce harm from cancer-associated thrombosis: The EMPOWER study. Res Pract Thromb Haemost. 2021;5(5):e12545doi: 10.1002/rth2.12545.
Baddeley, E., Torrens-Burton, A., Newman, A., Nelson, A., Pease, N., Nelson, R., & Noble, S. (2021). A mixed-methods study to evaluate a patient-designed tool to reduce harm from cancer-associated thrombosis: The EMPOWER study. Research and practice in thrombosis and haemostasis, 5(5), e12545. https://doi.org/10.1002/rth2.12545
Baddeley, Elin, et al. "A mixed-methods study to evaluate a patient-designed tool to reduce harm from cancer-associated thrombosis: The EMPOWER study." Research and practice in thrombosis and haemostasis vol. 5,5 (2021): e12545. doi: https://doi.org/10.1002/rth2.12545
Baddeley E, Torrens-Burton A, Newman A, Nelson A, Pease N, Nelson R, Noble S. A mixed-methods study to evaluate a patient-designed tool to reduce harm from cancer-associated thrombosis: The EMPOWER study. Res Pract Thromb Haemost. 2021 Aug 11;5(5):e12545. doi: 10.1002/rth2.12545. eCollection 2021 Jul. PMID: 34401640; PMCID: PMC8357625.
Copy Download .nbib Format: NLM
Phenotypic characterization of two novel cell line models of castration-resistant prostate cancer.

The Prostate

Haffner MC, Bhamidipati A, Tsai HK, Esopi DM, Vaghasia AM, Low JY, Patel RA, Guner G, Pham MT, Castagna N, Hicks J, Wyhs N, Aebersold R, De Marzo AM, Nelson WG, Guo T, Yegnasubramanian S.
PMID: 34402095
Prostate. 2021 Nov;81(15):1159-1171. doi: 10.1002/pros.24210. Epub 2021 Aug 16.

BACKGROUND: Resistance to androgen deprivation therapies is a major driver of mortality in advanced prostate cancer. Therefore, there is a need to develop new preclinical models that allow the investigation of resistance mechanisms and the assessment of drugs for...

Cite
Haffner MC, Bhamidipati A, Tsai HK, et al. Phenotypic characterization of two novel cell line models of castration-resistant prostate cancer. Prostate. 2021;81(15):1159-1171doi: 10.1002/pros.24210.
Haffner, M. C., Bhamidipati, A., Tsai, H. K., Esopi, D. M., Vaghasia, A. M., Low, J. Y., Patel, R. A., Guner, G., Pham, M. T., Castagna, N., Hicks, J., Wyhs, N., Aebersold, R., De Marzo, A. M., Nelson, W. G., Guo, T., & Yegnasubramanian, S. (2021). Phenotypic characterization of two novel cell line models of castration-resistant prostate cancer. The Prostate, 81(15), 1159-1171. https://doi.org/10.1002/pros.24210
Haffner, Michael C, et al. "Phenotypic characterization of two novel cell line models of castration-resistant prostate cancer." The Prostate vol. 81,15 (2021): 1159-1171. doi: https://doi.org/10.1002/pros.24210
Haffner MC, Bhamidipati A, Tsai HK, Esopi DM, Vaghasia AM, Low JY, Patel RA, Guner G, Pham MT, Castagna N, Hicks J, Wyhs N, Aebersold R, De Marzo AM, Nelson WG, Guo T, Yegnasubramanian S. Phenotypic characterization of two novel cell line models of castration-resistant prostate cancer. Prostate. 2021 Nov;81(15):1159-1171. doi: 10.1002/pros.24210. Epub 2021 Aug 16. PMID: 34402095; PMCID: PMC8460612.
Copy Download .nbib Format: NLM
Showing 865 to 873 of 873 entries